Mackenzie Financial Corp Harvard Bioscience Inc Call Options Transaction History
Mackenzie Financial Corp
- $65 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
92Shares Held
32.8MCall Options Held
4KPut Options Held
2.2K-
B. Riley Asset Management, LLC Dallas, TX2.83MShares$8.08 Million5.14% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$8.08 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.9 Million0.71% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.29 Million1.17% of portfolio
-
Amh Equity LTD2.32MShares$6.62 Million10.16% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $119M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...